Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) today released 30-day clinical outcomes for the DurAVR® THV in one hundred severe aortic stenosis patients with small ...
Growing concerns over foodborne illness and shifting consumer expectations for safe, transparent, and minimally processed food are accelerating the adoption of advanced pathogen detection technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback